Citius Pharmaceuticals, Inc.
CTXR
$0.968
-$0.021-2.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -66.17% | -81.84% | 42.61% | -38.27% | -23.17% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 73.92% | -- | -- | -- | -- |
| Prepaid Expenses | 5.40% | -73.25% | 11.99% | 14.62% | -0.32% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 28.88% | -49.22% | 29.81% | -23.52% | -17.92% |
|
|
|||||
| Total Current Assets | 28.88% | -49.22% | 29.81% | -23.52% | -17.92% |
| Net Property, Plant & Equipment | -22.26% | -17.91% | -14.99% | -12.87% | -11.19% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 0.00% | 56.23% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 3.47% | 20.15% | 7.03% | -6.87% | -5.99% |
|
|
|||||
| Total Accounts Payable | -77.90% | 1,903.68% | -37.69% | 0.84% | -9.57% |
| Total Accrued Expenses | 293.47% | -0.32% | 76.82% | -52.94% | 2.82% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -15.28% | 2.50% | 2.57% | 2.54% | 2.56% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 25.10% | 762.57% | -0.51% | -25.19% | -3.46% |
|
|
|||||
| Total Current Liabilities | 25.10% | 762.57% | -0.51% | -25.19% | -3.46% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -74.76% | -41.83% | -29.08% | -22.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.94% | 2.19% | 2.24% | 2.29% | 2.35% |
| Total Liabilities | 21.70% | 293.75% | 0.58% | -10.95% | -0.94% |
|
|
|||||
| Common Stock & APIC | 1.88% | -1.74% | 6.51% | 1.24% | 1.24% |
| Retained Earnings | -4.85% | -5.66% | -5.87% | -4.98% | -5.69% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -6.66% | -18.21% | 7.96% | -6.33% | -6.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.66% | -18.21% | 7.96% | -6.33% | -6.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -12.75% | 570.29% | 0.00% | 0.00% | 0.00% |
| Total Equity | -6.99% | -14.12% | 7.90% | -6.29% | -6.67% |
|
|
|||||